Share Your Feedback

Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likely Extremely likely
(Optional)
TMO

Thermo Fisher Scientific Inc

TMO Health technology
$211.6B
Market Cap

Shariah Analysis

Passed

Business Cash Liabilities

Based on AAOIFI screening standards, Thermo Fisher Scientific Inc appears to be Passed.

Business Activity
FYE 2024
Non-Permissible Income (<5%) 2.40%
Non-Permissible
$1.1K
Total Income
$45.9K
Revenue Breakdown
Life Sciences Solutions
$9.6K
Analytical Instruments
$7.5K
Specialty Diagnostics
$4.5K
Laboratory Products and Biopharma Services
$23.2K
Interest income
Non-Operating
$1.1K
Non-Compliant: $1.1K
Other income/(expense)
Non-Operating
$12
Non-Compliant: $12
Israel involvement

Israel Involvement

Total Funded
$132.0M
Employees in Israel
201-500
Companies Funded
1
Overview

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease.Thermo Fisher Israel operates as a Materials & Structural Analysis Division (MSD), which supplies innovative solutions for microscopy and microanalysis.

Israeli Portfolio
CytoReason
CytoReason

Machine Learning for Data-driven Target Discovery and Drug Development

Raised: $132M 51-200

Market Data

Exchange NYSE NYSE
Currency USD
Country United States
Last Updated 2025-12-22

Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.

Advertisement Banner